Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 10/20 | 0.48 |
| ▸ | CHRNA4 | P43681 | 10/20 | 0.48 |
| ▸ | CHRNB4 | P30926 | 8/20 | 0.48 |
| ▸ | CHRNA3 | P32297 | 6/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28856626 | 0.97 | CHRNB2 (0.50) | CHRNB2CHRNA4CHRNB4CHRNA3LMNA | |
| SCHEMBL3106239 | 0.90 | — | — | |
| SCHEMBL9088 | 0.78 | — | — | |
| SCHEMBL27696866 | 0.78 | LMNA (0.36) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL27696855 | 0.78 | LMNA (0.36) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL27696868 | 0.78 | LMNA (0.36) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL14923243 | 0.78 | LMNA (0.36) | LMNAALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL1024279 | 0.77 | OPRM1 (0.46) | CHRNB2CHRNA4CHRNB4LMNATSHR | |
| SCHEMBL37596 | 0.77 | OPRM1 (0.46) | CHRNB2CHRNA4CHRNB4LMNATSHR | |
| SCHEMBL20747520 | 0.77 | OPRM1 (0.46) | CHRNB2CHRNA4CHRNB4LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1630185-B2 | Process of manufacture of polyurethane slabstock foam | BASF SE (DE) | 2010-12-22 | — | — | EP | claimed |
| EP-1630185-B1 | Process of manufacture of polyurethane slabstock foam | BASF AG (DE) | 2008-02-20 | — | — | EP | claimed |
| EP-1630185-A1 | Process of manufacture of polyurethane slabstock foam | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-01 | — | — | EP | claimed |
| US-20250163205-A1 | USE OF RECYCLED POLYOL FROM AMINE-BASED HYDROLYSIS PROCESS TO PRODUCE PU FOAM | EVONIK OPERATIONS GMBH (DE) | 2025-05-22 | — | — | US | disclosed |
| US-20240309145-A1 | PRODUCTION OF PU FOAMS | EVONIK OPERATIONS GMBH (DE) | 2024-09-19 | — | — | US | disclosed |
| EP-4363473-A1 | PRODUCTION OF PU FOAMS | Evonik Operations GmbH (DE) | 2024-05-08 | — | — | EP | disclosed |
| EP-4355804-A1 | SHAPED FLEXIBLE PU FOAM ARTICLES | Evonik Operations GmbH (DE) | 2024-04-24 | — | — | EP | disclosed |
| CN-117597373-A | Production of PU foam | 赢创运营有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-117529512-A | Molded flexible polyurethane foam article | 赢创运营有限公司 | 2024-02-06 | — | — | CN | disclosed |
| WO-2023161253-A1 | USE OF RECYCLED POLYOL FROM AMINE-BASED HYDROLYSIS PROCESS TO PRODUCE PU FOAM | EVONIK OPERATIONS GMBH (DE) | 2023-08-31 | — | — | WO | disclosed |
| EP-3337838-B1 | POLYURETHANE FLEXIBLE FOAMS WITH INCREASED HARDNESS | EVONIK OPERATIONS GMBH (DE) | 2023-06-21 | — | — | EP | disclosed |
| US-8247467-B2 | Process for producing flexible polyurethane foams | BASF AKTIENGESELLSCHAFT (DE) | 2012-08-21 | — | — | US | disclosed |
| EP-2091990-B1 | PROCESS FOR PRODUCING FLEXIBLE POLYURETHANE FOAMS | BASF SE (DE) | 2011-06-29 | — | — | EP | disclosed |
| EP-1630185-B2 | Process of manufacture of polyurethane slabstock foam | BASF SE (DE) | 2010-12-22 | — | — | EP | disclosed |
| US-20090306239-A1 | PROCESS FOR PRODUCING FLEXIBLE POLYURETHANE FOAMS | BASF SE (DE) | 2009-12-10 | — | — | US | disclosed |
| CN-101535364-A | Process for producing flexible polyurethane foams | BASF SE (DE) | 2009-09-16 | — | — | CN | disclosed |
| EP-2091990-A1 | PROCESS FOR PRODUCING FLEXIBLE POLYURETHANE FOAMS | BASF SE (DE) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008058913-A1 | PROCESS FOR PRODUCING FLEXIBLE POLYURETHANE FOAMS | BASF SE (DE) | 2008-05-22 | — | — | WO | disclosed |
| EP-1630185-B1 | Process of manufacture of polyurethane slabstock foam | BASF AG (DE) | 2008-02-20 | — | — | EP | disclosed |
| EP-1630185-A1 | Process of manufacture of polyurethane slabstock foam | BASF AKTIENGESELLSCHAFT (DE) | 2006-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090306239-A1 | PROCESS FOR PRODUCING FLEXIBLE POLYURETHANE FOAMS | FGB, PUF60, PARG | CHRNB2 3504/4885CHRNA4 4296/4885CHRNB4 3555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.